| Name | Title | Contact Details |
|---|
Easic provides the ability to innovate and create differentiated products based on customized silicon devices. eASIC's unique Single Mask Adaptable ASIC devices dramatically reduce overall cost, time-to-production and power consumption while increasing performance. eASIC offers a comprehensive product portfolio to meet the most demanding needs whether it be performance, cost, power or time-to-market.
Xceleron believes that AMS technology and our expertise can get life-changing products (drugs and biobased) quickly and cost-effectively to people who need them. We work with integrity and an open mind and are driven by science and the spirit of collaboration. Founded in 1997 in York, UK, and now headquartered in Germantown, Maryland, Xceleron pioneered human microdose and microtracer techniques using AMS to investigate the pharmacokinetics and metabolism of developmental drugs in Phase 0, Phase I, and Phase II/III clinical trials. Xceleron’s experience is especially valuable because the characteristics of many contemporary small molecules (low solubility, long half-life and disproportionate human metabolites) mean that their early pharmacokinetic and metabolic characterization is critical to the cost-effectiveness of clinical development.
Unitechno is a Cupertino, CA-based company in the Computers and Electronics sector.
Rubycon America is a Gurnee, IL-based company in the Computers and Electronics sector.
Kovio, Inc. is one of the leading companies in the Computers and Electronics sector.